Iron metabolism and drug resistance in cancer

被引:90
作者
Kazan, Hasan Huseyin [1 ]
Urfali-Mamatoglu, Cagri [1 ]
Gunduz, Ufuk [1 ]
机构
[1] Middle East Tech Univ, Dept Biol, Univ Mah Dumlupinar Blv 1, TR-06800 Ankara, Turkey
关键词
Iron metabolism; Chemotherapy; Drug resistance; Ferroptosis; DOXORUBICIN-TRANSFERRIN CONJUGATE; AGENT GALLIUM NITRATE; HUMAN-LEUKEMIC-CELLS; MULTIDRUG-RESISTANCE; BREAST-CANCER; CHEMOTHERAPEUTIC-AGENTS; RECEPTOR EXPRESSION; MULTIPLE-MYELOMA; CARCINOMA CELLS; P-GLYCOPROTEIN;
D O I
10.1007/s10534-017-0037-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron is an essential inorganic element for various cellular events. It is directly associated with cell proliferation and growth; therefore, it is expected that iron metabolism is altered in tumor cells which usually have rapid growth rates. The studies on iron metabolism of tumor cells have shown that tumor cells necessitated higher concentrations of iron and the genes of iron uptake proteins were highly over-expressed. However, there are limited number of studies on overall iron metabolism in drug-resistant tumor cells. In this article, we evaluated the studies reporting the relationship between drug resistance and iron metabolism and the utilization of this knowledge for the reversal of drug resistance. Also, the studies on iron-related cell death mechanism, ferroptosis, and its relation to drug resistance were reviewed. We focus on the importance of iron metabolism in drug-resistant cancer cells and how alterations in iron metabolism participate in drug-resistant phenotype.
引用
收藏
页码:629 / 641
页数:13
相关论文
共 95 条
[1]   Nuclear ferritin: A new role for ferritin in cell biology [J].
Alkhateeb, Ahmed A. ;
Connor, James R. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2010, 1800 (08) :793-797
[2]   Low-dose chemotherapeutic drugs induce reactive oxygen species and initiate apoptosis-mediated genomic instability [J].
Arun, Renganathan ;
Dhivya, Sridaran ;
Abraham, Suresh K. ;
Premkumar, Kumpati .
TOXICOLOGY RESEARCH, 2016, 5 (02) :547-556
[3]   TRANSFERRIN RECEPTORS ASSOCIATE WITH DRUG-RESISTANCE IN CANCER-CELLS [J].
BARABAS, K ;
FAULK, WP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) :702-708
[4]   MUTATED RECOMBINANT HUMAN HEAVY-CHAIN FERRITINS AND MYELOSUPPRESSION INVITRO AND INVIVO - A LINK BETWEEN FERRITIN FERROXIDASE ACTIVITY AND BIOLOGICAL FUNCTION [J].
BROXMEYER, HE ;
COOPER, S ;
LEVI, S ;
AROSIO, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (03) :770-774
[5]   Iron increases the susceptibility of multiple myeloma cells to bortezomib [J].
Campanella, Alessandro ;
Santambrogio, Paolo ;
Fontana, Francesca ;
Frenquelli, Michela ;
Cenci, Simone ;
Marcatti, Magda ;
Sitia, Roberto ;
Tonon, Giovanni ;
Camaschella, Clara .
HAEMATOLOGICA, 2013, 98 (06) :971-979
[6]   Interaction of anthracyclines with iron responsive element mRNAs [J].
Canzoneri, Joshua C. ;
Oyelere, Adegboyega K. .
NUCLEIC ACIDS RESEARCH, 2008, 36 (21) :6825-6834
[7]   Mechanisms of ferroptosis [J].
Cao, Jennifer Yinuo ;
Dixon, Scott J. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (11-12) :2195-2209
[8]   Proteasome inhibition in multiple myeloma: Therapeutic implication [J].
Chauhan, D ;
Hideshima, T ;
Anderson, KC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :465-476
[9]  
Chekhun V. F., 2017, Experimental Oncology, V39, P25
[10]  
Chekhun V. F., 2014, Experimental Oncology, V36, P196